PDF Version

PDF 版本

AUDUBON, Pa.

奥杜邦，宾夕法尼亚州

,

，

March 11, 2025

2025年3月11日

(GLOBE NEWSWIRE) --

（环球新闻网）--

Globus Medical

环球医疗

, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches:

公司（纽约证券交易所代码：GMED），一家领先的肌肉骨骼技术公司，今天宣布了两项商业发布：

COHERE™ ALIF Spacer

COHERE™ ALIF 支架

: The first Porous PEEK™ interbody spacer for anterior lumbar interbody fusion (ALIF) surgery, and

：首款用于前路腰椎间体融合术（ALIF）的多孔PEEK™椎间间隔器，以及

Modulus™ ALIF Blades

模量™ ALIF 刀片

: An extension of the market-leading Modulus™ ALIF interbody spacer system.

：市场领先的Modulus™ ALIF椎间融合器系统的一个扩展。

The COHERE ™ ALIF Spacer is the latest addition to Globus Medical’s Advanced Materials Science™ (AMS) implant portfolio, featuring proprietary porous surface technology designed for bone in-growth while maintaining the imaging and mechanical properties favored in a solid PEEK interbody spacer.

COHERE™ ALIF 间隔器是 Globus Medical 先进材料科学™（AMS）植入物产品组合的最新成员，具有专有的多孔表面技术，旨在促进骨长入，同时保留固体 PEEK 椎间融合器所青睐的成像和机械性能。

1,2

1,2

“Porous PEEK combines the stiffness and radiolucency of PEEK with the osseointegration potential offered by the porous technology,”

“多孔PEEK结合了PEEK的刚性和射线可透性，以及多孔技术提供的骨整合潜力。”

1,3

1,3

said Frank Phillips, MD, professor of orthopedic surgery and fellowship director of the Division of Spine Surgery at Rush University Medical Center in Chicago. “The enhanced clinical outcomes possible with Cohere™ Porous PEEK for anterior cervical fusion

芝加哥拉什大学医学中心脊柱外科主任、骨科手术教授弗兰克·菲利普斯医学博士说：“使用Cohere™多孔PEEK进行前颈椎融合术可能带来的临床效果提升”。

4

4

and the comprehensive surface technology options available are now also helping to advance patient care for anterior lumbar spine surgery. In addition, the ability to radiographically assess fusion is a significant clinical benefit.”

全面的表面技术选项现在也有助于推动前路腰椎手术的患者护理。此外，能够通过放射学评估融合情况是一项重要的临床优势。

Modulus™ ALIF Blades extend the versatility of the Modulus™ ALIF Spacer portfolio by offering surgeons different fixation options with the same interbody spacer. Procedural efficiency is achieved with Modulus™ ALIF Blades through the ability to deliver anchoring blade fixation immediately following interbody spacer placement to reduce the number of surgical steps and instruments needed in the procedure. .

Modulus™ ALIF 刀片通过为外科医生提供使用相同椎间融合器的不同固定选项，扩展了 Modulus™ ALIF 椎间融合器系列的多功能性。Modulus™ ALIF 刀片通过在椎间融合器放置后立即进行锚定刀片固定，减少了手术步骤和所需器械的数量，从而提高了手术效率。

“Modulus™ ALIF with the anchoring blade option makes anterior spine surgery even more efficient while potentially reducing complications by reducing the number of instrument passes adjacent to major vessels,” said

“Modulus™ ALIF 通过增加锚定叶片选项，使得前路脊柱手术更加高效，同时通过减少靠近主要血管的器械传递次数，有可能降低并发症的发生率，”

Anthony Kwon

安东尼·权

, MD, Orthopedic Spine Surgeon practicing at OrthoCarolina’s Spine Center and

，医学博士，执业于OrthoCarolina脊柱中心的骨科脊柱外科医生，

Atrium Medical Center

阿特里姆医疗中心

in

在

Charlotte, NC

夏洛特，北卡罗来纳州

. “The low-profile instrumentation and streamlined delivery of fixation also helps to reduce the exposure window traditionally needed for anterior surgery, allowing for a more minimally invasive approach”.

“低调的仪器设计和简化的固定输送方式还有助于减少传统前路手术通常需要的暴露时间，从而实现更微创的方法”。

These two new offerings strengthen Globus Medical’s comprehensive anterior spine portfolio, designed to address a variety of the most challenging procedures in spine surgery. The integration of a Porous PEEK interbody spacer option and Modulus anchor fixation demonstrate Globus Medical’s commitment to providing surgeon partners with procedurally integrated ALIF solutions..

这两款新产品加强了Globus Medical全面的前路脊柱产品组合，旨在应对脊柱手术中各种最具挑战性的手术。通过整合多孔PEEK椎间融合器选项和Modulus锚定固定技术，Globus Medical展现了其为外科医生伙伴提供程序化整合的ALIF解决方案的承诺。

“These products underscore our commitment to advancing surgical outcomes and providing spine surgeons with best-in-class solutions that span varying patient anatomy and surgeon preference to provide the best possible care in their hands,” said David Hole, president of Spine at Globus Medical. “We remain dedicated to delivering innovation through our product development engine to solve the unmet clinical needs of our surgeon partners while helping to improve patient care.”.

“这些产品彰显了我们对手术结果的承诺，以及为脊柱外科医生提供一流的解决方案的决心。我们的解决方案涵盖不同的患者解剖结构和外科医生的偏好，旨在他们手中提供尽可能最好的护理。”Globus Medical脊柱部门总裁David Hole表示，“我们始终致力于通过我们的产品开发引擎进行创新，以解决外科医生合作伙伴尚未满足的临床需求，同时帮助改善患者护理。”

About

关于

Globus Medical, Inc.

环球医疗公司

Globus Medical, Inc.

环球医疗公司

is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies.

是一家领先的全球肌肉骨骼公司，致力于解决未满足的临床需求并改变生活。我们以紧迫的灵感进行创新，提供世界级的教育和临床支持，并在整个脊柱、骨科创伤、关节重建、生物材料和赋能技术领域推进护理。

Additional information can be accessed at .

更多信息可以访问。

https://www.globusmedical.com/

https://www.globusmedical.com/

.

。

References:

参考文献：

1. Evans NT, Torstrick FB, Lee CS, et al. High-strength, surface-porous polyether-ether-ketone for load-bearing orthopedic implants.

1. Evans NT, Torstrick FB, Lee CS, 等。用于承重骨科植入物的高强度表面多孔聚醚醚酮。

Acta Biomater

生物材料学报

2015;13:159-67.

2015；13：159-67。

2. Torstrick FB, Lin ASP, Potter D, et al. Porous PEEK improves the bone-implant interface compared to plasma-sprayed titanium coating on PEEK.

2. Torstrick FB, Lin ASP, Potter D, 等。与PEEK上的等离子喷涂钛涂层相比，多孔PEEK改善了骨-植入物界面。

Biomaterials

生物材料

2018;185:106-16

2018；185：106-16

3. Torstrick FB, Evans NT, Stevens HY, et al. Do surface porosity and pore size influence mechanical properties and cellular response to PEEK?

3. Torstrick FB, Evans NT, Stevens HY, 等。表面孔隙率和孔径是否影响PEEK的机械性能和细胞反应？

Clin Orthop Relat Res

临床骨科及相关研究

2016;474(11):2373-83.

2016；474（11）：2373-83。

4. Hill CP and Strenge KB. Early clinical outcomes comparing porous PEEK, smooth PEEK, and structural allograft interbody devices for anterior cervical discectomy and fusion.

4. Hill CP 和 Strenge KB。早期临床结果比较了多孔PEEK、光滑PEEK和结构性同种异体移植椎间装置在前路颈椎间盘切除融合术中的应用。

J Spine Neurosurg

脊柱神经外科杂志

2019;8(1):1-7.

2019；8（1）：1-7。

Safe Harbor Statements

安全港声明

All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms.

本新闻稿中包含的所有非历史事实的声明均为前瞻性声明，可以通过使用诸如“相信”、“可能”、“或许”、“能够”、“将”、“目标”、“估计”、“继续”、“预期”、“打算”、“期望”、“计划”等类似词语来识别。

These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted.

这些前瞻性陈述基于我们对当前未来事件和趋势的假设、预期和估计。前瞻性陈述仅为预测，受许多可能影响我们业务和运营的风险、不确定性和其他因素的影响，实际结果可能与预测大不相同。

These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of, and the ability of .

这些风险和不确定性包括但不限于与整合相关的风险和成本，以及能力。

Globus Medical

环球医疗

and

和

NuVasive

诺华asive

to integrate, their businesses successfully and to achieve anticipated synergies, health epidemics, pandemics and similar outbreaks, including the COVID-19 pandemic, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks.

成功整合其业务并实现预期的协同效应，健康流行病、大流行病及类似疫情（包括新冠疫情），影响我们季度业绩的因素，我们管理增长的能力，我们维持盈利能力的能力，对我们产品的需求，我们成功竞争的能力（包括但不限于说服外科医生使用我们产品的能力以及吸引和留住销售及其他人员的能力），我们快速开发和推出新产品的能力，我们制定和执行成功商业战略的能力，我们遵守适用于我们业务的法律法规的能力，我们保护知识产权的能力，我们在应对针对我们的法律诉讼中的成功，医疗器械行业的趋势，总体经济状况，以及其他风险。

For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the .

要讨论这些可能影响我们结果的风险、不确定性和其他因素，您应参阅我们最近提交的年度报告表格10-K中的披露内容。

Securities and Exchange Commission

证券交易委员会

, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the

，包括标记为“风险因素”和“关于前瞻性陈述的警告性声明”的部分，以及我们提交的10-Q表格、8-K表格和其他文件中。

Securities and Exchange Commission

证券交易委员会

. These documents are available at

这些文档可以在以下位置获得：

www.sec.gov

www.sec.gov

. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

此外，我们处在一个不断变化的环境中。新的风险因素和不确定性不时出现，我们无法预测所有风险因素和不确定性，也无法评估所有因素对我们业务的影响，或任何因素或因素组合可能导致实际结果与任何前瞻性声明中包含的结果存在重大差异的程度。

Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof..

鉴于这些风险和不确定性，提醒读者不要过分依赖任何前瞻性陈述。本新闻稿中包含的前瞻性陈述仅截至本新闻稿发布之日。我们不承担因新信息、事件或其他情况或此后我们注意到的因素而更新任何前瞻性陈述的义务。

Investor contact:

投资者联系人：

Brian Kearns

布赖恩·基恩斯

610-930-1800

610-930-1800

investors@globusmedical.com

投资者@globusmedical.com

Media contact:

媒体联系人：

Moran Chavez

莫兰·查韦斯

media@globusmedical.com

媒体@globusmedical.com

Source: Globus Medical

来源：Globus Medical